giant ragweed pollen extract 50 MG/ML / western ragweed pollen extract 50 MG/ML Injectable Solution
RxNorm concept 896177, clinical drug (scd). Prescribable name: giant ragweed pollen extract 50 MG/ML / short ragweed pollen extract 50 MG/ML Injectable Solution.
- RxCUI
- 896177
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/896177 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Ambrosia artemisiifolia pollen extract 0.05 GM/ML / Ambrosia trifida pollen extract 0.05 GM/ML Injectable Solution; Ambrosia artemisiifolia pollen extract 50 MG/ML / Ambrosia trifida pollen extract 50 MG/ML Injectable Solution
Related concepts
- western ragweed pollen extract 50 MG/ML (SCDC, consists of)
- giant ragweed pollen extract 50 MG/ML (SCDC, consists of)
- Injectable Solution (DF, has dose form)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 896177 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/896177 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 896177. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.